Lupin informs about press release

17 Feb 2023 Evaluate

Lupin has informed that it enclosed a press release as regards receipt of Establishment Inspection Report from the U.S. FDA for the Company’s new injectable facility located in Nagpur, India.

The above information is a part of company’s filings submitted to BSE.




Lupin Share Price

2150.25 18.45 (0.87%)
30-Jan-2026 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1598.00
Dr. Reddys Lab 1215.70
Cipla 1328.40
Zydus Lifesciences 888.50
Lupin 2150.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×